Alpha

Noah Holdings Wins 'Best Independent Wealth Manager - China' Award for Seventh Year in a Row

Retrieved on: 
Friday, March 8, 2024

The organization's annual APB Summit in Hong Kong and Singapore caters to a wide audience within the private wealth management community.

Key Points: 
  • The organization's annual APB Summit in Hong Kong and Singapore caters to a wide audience within the private wealth management community.
  • "Chinese wealth manager Noah Holdings continues its offshore expansion, tapping Chinese clients who wants to go global.
  • These results highlighted the Company's strong performance and the trust that clients place in it as private wealth manager.
  • Mr. Yin Zhe, Co-Founder and CEO of Noah, commented "2023 was a tremendous year for Noah and we are honored to receive the "Best Independent Wealth Manager - China" award for the seventh time.

Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, March 7, 2024

We are also exploring the addition of new clinical trials in the U.S., based upon recent positive regulatory feedback.

Key Points: 
  • We are also exploring the addition of new clinical trials in the U.S., based upon recent positive regulatory feedback.
  • The Alpha DaRT procedure was deemed technically successful in all five cases, with Alpha DaRT sources successfully inserted into the target tumors.
  • Targeting completion of patient recruitment in the ReSTART pivotal U.S. multi-center trial in recurrent cutaneous squamous cell carcinoma in H2 2024.
  • The Company expects that this cash balance will be sufficient to fund operations for at least two years.

Reaktor ($RKR) Launches to Transform Web3 Gaming with Groundbreaking Layer 1 and Mining Innovations

Retrieved on: 
Monday, March 4, 2024

Huntsville Alabama, March 04, 2024 (GLOBE NEWSWIRE) -- Lion’s Share Group is excited to unveil Reaktor, a pioneering initiative poised to transform the Web3 gaming landscape through its Gaming Blockchain L1, Game Distribution Platform and Mining technologies.

Key Points: 
  • Huntsville Alabama, March 04, 2024 (GLOBE NEWSWIRE) -- Lion’s Share Group is excited to unveil Reaktor, a pioneering initiative poised to transform the Web3 gaming landscape through its Gaming Blockchain L1, Game Distribution Platform and Mining technologies.
  • In the rapidly evolving Web3 domain, Reaktor stands out as a key innovator in gaming, Layer 1 blockchain, and mining, spearheaded by Jerry Waugh of uNhumanly LLC.
  • This venture is set to start a new wave of innovation across the Web3 ecosystem, enhancing user engagement within both Web3 and traditional gaming communities.
  • Backed by a visionary team and pioneering technology, Reaktor is on course to redefine the realms of Web3 gaming, mining, and decentralized finance.

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

Retrieved on: 
Monday, March 4, 2024

LANGHORNE, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, is scheduled to present at the iAccess Alpha Best Ideas Spring Virtual Conference taking place March 12th and 13th.

Key Points: 
  • LANGHORNE, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, is scheduled to present at the iAccess Alpha Best Ideas Spring Virtual Conference taking place March 12th and 13th.
  • To schedule a 1x1 meeting, please contact your iAccess Alpha conference representative or KCSA by emailing [email protected] .

Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference

Retrieved on: 
Monday, February 26, 2024

JERUSALEM, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that management will participate at the Barclays 26th Annual Global Healthcare Conference on March 12th and 13th, 2024.

Key Points: 
  • JERUSALEM, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that management will participate at the Barclays 26th Annual Global Healthcare Conference on March 12th and 13th, 2024.

MarketVector Indexes Licenses REIT Index to Tidal to Capture REIT Opportunity

Retrieved on: 
Wednesday, March 6, 2024

MarketVector IndexesTM (“MarketVector”) announces the licensing of the iREIT®-MarketVectorTM Quality REIT Index (ticker: IRET) to Tidal Investments, LLC (“Tidal”), highlighting MarketVector’s ability to provide customizable indexes in varying sectors for clients across the globe.

Key Points: 
  • MarketVector IndexesTM (“MarketVector”) announces the licensing of the iREIT®-MarketVectorTM Quality REIT Index (ticker: IRET) to Tidal Investments, LLC (“Tidal”), highlighting MarketVector’s ability to provide customizable indexes in varying sectors for clients across the globe.
  • In partnership with Tidal, leading real estate analyst Brad Thomas, CEO of Wide Moat Research, launched the IRET ETF (ticker: IRET) built on an index Brad designed with MarketVector.
  • "Gearing up to support the launch of the IRET ETF in partnership with MarketVector and Brad Thomas is truly exciting for us at Tidal Financial Group.
  • We're thrilled to offer investors an opportunity to access quality REITs through this innovative product,“ said Gavin Filmore, CRO of Tidal.

Logik.io Grows 230% in 2023, Marks Third Consecutive Year of Triple-Digit Revenue Growth

Retrieved on: 
Tuesday, March 5, 2024

Logik.io, the company consumerizing enterprise selling experiences with advanced configuration technology, today announced that the company has posted its third consecutive year triple-digit revenue growth.

Key Points: 
  • Logik.io, the company consumerizing enterprise selling experiences with advanced configuration technology, today announced that the company has posted its third consecutive year triple-digit revenue growth.
  • Logik.io has reported 230% year-over-year revenue growth from January 2023 to January 2024, furthering its leadership position, along with a variety of additional growth results.
  • View the full release here: https://www.businesswire.com/news/home/20240305026875/en/
    Over the same period that Logik.io grew its revenue by 230%, the company also doubled its live customer base.
  • “Logik.io’s impressive growth is a direct result of our unwavering commitment to innovating for our customers,” said Christopher Shutts, CEO of Logik.io.

Gabather reports initial positive results from the EEG/fMRI target engagement study

Retrieved on: 
Thursday, March 7, 2024

STOCKHOLM, March 7, 2024 /PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) today reports initial positive results from the EEG/fMRI target engagement study, a double-blinded placebo-controlled, cross-over phase Ib study of Gabather's GABAA-receptor positive allosteric modulator, GT-002, in healthy volunteers.

Key Points: 
  • STOCKHOLM, March 7, 2024 /PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) today reports initial positive results from the EEG/fMRI target engagement study, a double-blinded placebo-controlled, cross-over phase Ib study of Gabather's GABAA-receptor positive allosteric modulator, GT-002, in healthy volunteers.
  • The study met the primary objective to confirm a favourable safety and tolerability profile of GT-002.
  • The secondary objective to demonstrate target engagement in human brain was also met.
  • The study clearly demonstrated that GT-002 is safe and well tolerated at dose levels expected to be effective for treatment of patients with neuropsychiatric disorders.

Gabather reports initial positive results from the EEG/fMRI target engagement study

Retrieved on: 
Thursday, March 7, 2024

STOCKHOLM, March 7, 2024 /PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) today reports initial positive results from the EEG/fMRI target engagement study, a double-blinded placebo-controlled, cross-over phase Ib study of Gabather's GABAA-receptor positive allosteric modulator, GT-002, in healthy volunteers.

Key Points: 
  • STOCKHOLM, March 7, 2024 /PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) today reports initial positive results from the EEG/fMRI target engagement study, a double-blinded placebo-controlled, cross-over phase Ib study of Gabather's GABAA-receptor positive allosteric modulator, GT-002, in healthy volunteers.
  • The study met the primary objective to confirm a favourable safety and tolerability profile of GT-002.
  • The secondary objective to demonstrate target engagement in human brain was also met.
  • The study clearly demonstrated that GT-002 is safe and well tolerated at dose levels expected to be effective for treatment of patients with neuropsychiatric disorders.

Firefly Aerospace Doubles Facilities in Briggs, Texas to Support Medium Launch Vehicle

Retrieved on: 
Wednesday, February 28, 2024

BRIGGS, Texas, Feb. 28, 2024 /PRNewswire/ -- Firefly Aerospace, Inc., an end-to-end space transportation company, today held an official ribbon cutting in celebration of the company's Rocket Ranch expansion in Briggs, Texas. Firefly more than doubled the size of its manufacturing facilities, added two new test stands, and installed state-of-the-art machinery to support the production of Northrop Grumman's Antares 330 and the Medium Launch Vehicle (MLV) the companies are co-developing together. 

Key Points: 
  • BRIGGS, Texas, Feb. 28, 2024 /PRNewswire/ -- Firefly Aerospace, Inc. , an end-to-end space transportation company, today held an official ribbon cutting in celebration of the company's Rocket Ranch expansion in Briggs, Texas.
  • Firefly more than doubled the size of its manufacturing facilities, added two new test stands, and installed state-of-the-art machinery to support the production of Northrop Grumman's Antares 330 and the Medium Launch Vehicle (MLV) the companies are co-developing together.
  • Firefly's expanded manufacturing space from 92,000 to 207,000 square feet includes two new large-scale buildings for rocket production, assembly, and integration.
  • In total, Firefly now has six test stands at its Briggs location to support the robust testing performed across all vehicle lines.